JBTM Bulls Eye the Print After a Brutal Year

JBT Marel Corporation heads into its November 3 earnings release with options traders leaning more bullish than at any point in the past year, even as short sellers have quietly built positions to their highest level in months.

The most striking signal into the print is from the options market. The put/call ratio has collapsed to 0.078, the lowest reading in the past 52 weeks, and sits about one standard deviation below its 20-day average of 0.113. That gap between current positioning and the recent norm reflects an unusually strong tilt toward calls rather than defensive puts. The stock has helped the case for optimism: JBTM has gained roughly 5% over the past week to close at $114.78, a small but steady recovery. Borrow conditions are loose, with availability running at 327%, meaning shares are plentiful for anyone who wants to short, and cost to borrow is negligible at 0.46%.

The short interest picture cuts against the bullish options read. Short interest has climbed 6.6% over the past month to 8.2% of the free float, with roughly 4.3 million shares sold short as of October 30. Days to cover are elevated at 9.3 days per the latest FINRA data, meaning any forced covering would take time to unwind. The ORTEX short score of 60.6 has held in a narrow band for the past two weeks, suggesting shorts are not in retreat. Positioning looks divided rather than consensus: call buyers are betting on recovery while a material short base bets the other way.

The analytical community has been broadly constructive on the stock. The consensus price target of $162.71 implies roughly 42% upside from the current price. Baird trimmed its target from $188 to $171 in late September while keeping an Outperform rating. Barclays and Keybanc both initiated with Overweight ratings and $150 targets after the summer. The bull case rests on the post-Marel integration delivering margin improvement and order flow recovery. Bears point to a poor track record on earnings surprises: the factor score for EPS surprise ranks in just the 11th percentile, and EPS momentum over the past 90 days ranks in the 30th percentile. The PE stands at 12.7x, which is undemanding in isolation, but forward EPS growth expectations have been revised lower repeatedly.

Recent earnings history reinforces why the short base has not fled. The last two prints both produced immediate double-digit declines: the August 2026 release was followed by a 14.2% drop over one day and a 14.4% fall over five days. The prior quarter saw a smaller single-day move of roughly 0.2%, but a 6.4% drift lower over the following week. Three consecutive earnings prints with negative five-day reactions is a consistent pattern. The institutional register is concentrated: BlackRock holds 15.4% and T. Rowe Price holds 9.6%, both adding shares in the most recent reported quarter. Eyrir Invest hf., which filed a Schedule 13D and held 6.6% at its peak, has since reduced its stake to 0.5% as of its March 2025 filing, an exit worth noting even though 13D positions are as-last-disclosed and further movement below the 5% threshold may go unreported.

The print is therefore a test of whether the Marel integration has turned a corner on margins and order intake, or whether the company's habit of missing estimates survives into a third consecutive quarter.